Literature DB >> 20719340

Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome.

J Curtis Nickel1, Dean A Tripp, Michel Pontari, Robert Moldwin, Robert Mayer, Lesley K Carr, Ragi Doggweiler, Claire C Yang, Nagendra Mishra, Jorgen Nordling.   

Abstract

PURPOSE: We characterized and compared the impact of clinical phenotypic associations between interstitial cystitis/painful bladder syndrome and controls in relation to potentially related conditions, particularly irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome.
MATERIALS AND METHODS: Female patients with interstitial cystitis/painful bladder syndrome and controls with no interstitial cystitis/painful bladder syndrome completed a biopsychosocial phenotyping questionnaire battery which included demographics/history form, self-reported history of associated conditions, and 10 validated questionnaires focused on symptoms, suffering/coping and behavioral/social factors.
RESULTS: Questionnaires were completed by 205 patients with interstitial cystitis/painful bladder syndrome and 117 controls matched for age. Prevalence of self-reported associated condition diagnosis in interstitial cystitis/painful bladder syndrome vs controls was irritable bowel syndrome 38.6% vs 5.2%, fibromyalgia 17.7% vs 2.6% and chronic fatigue syndrome 9.5% vs 1.7% (all p <0.001). In the interstitial cystitis/painful bladder syndrome cohort 50.3% reported no other associated condition, 24.4% had interstitial cystitis/painful bladder syndrome + irritable bowel syndrome only, 2.5% had interstitial cystitis/painful bladder syndrome + fibromyalgia only, 1.5% had interstitial cystitis/painful bladder syndrome + chronic fatigue syndrome only, while 20.2% had multiple associated conditions. As the number of associated conditions increased (ie localized, regional, systemic), pain, stress, depression and sleep disturbance increased while social support, sexual functioning and quality of life deteriorated. Anxiety and catastrophizing remained increased in all groups. Symptom duration was associated with this apparent phenotypic progression.
CONCLUSIONS: Irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome are more prevalent in patients with interstitial cystitis/painful bladder syndrome than in asymptomatic control subjects, and result in significant impact. There are at least 3 distinct clinical phenotypes based on identification of overlapping syndrome patterns. A suggestion that remains to be proven with longitudinal studies is that there may be progression over time from an organ centric to a regional and finally to a systemic pain syndrome with progression of symptom severity, and deterioration of cognitive and psychosocial parameters.
Copyright © 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20719340     DOI: 10.1016/j.juro.2010.06.005

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  61 in total

1.  Time-dependent changes in bladder function and plantar sensitivity in a rat model of fibromyalgia syndrome induced by hydrochloric acid injection into the gluteus.

Authors:  Akira Furuta; Yasuyuki Suzuki; Mariko Honda; Yusuke Koike; Takehito Naruoka; Koji Asano; Michael Chancellor; Shin Egawa; Naoki Yoshimura
Journal:  BJU Int       Date:  2011-08-02       Impact factor: 5.588

2.  Early experience with topical meloxicam and lidocaine combination for the treatment of vulvodynia.

Authors:  Rufina Kim; Kerri-Lynn Kelly; Merle Olson; J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2018-04-06       Impact factor: 1.862

Review 3.  Urine Trouble: Alterations in Brain Function Associated with Bladder Pain.

Authors:  Katelyn E Sadler; Benedict J Kolber
Journal:  J Urol       Date:  2016-02-22       Impact factor: 7.450

4.  Factors associated with vulvodynia incidence.

Authors:  Barbara D Reed; Laurie J Legocki; Melissa A Plegue; Ananda Sen; Hope K Haefner; Sioban D Harlow
Journal:  Obstet Gynecol       Date:  2014-02       Impact factor: 7.661

Review 5.  Interstitial cystitis/bladder pain syndrome: diagnosis and management.

Authors:  I Offiah; S B McMahon; B A O'Reilly
Journal:  Int Urogynecol J       Date:  2013-02-22       Impact factor: 2.894

6.  Multiple sensitivity phenotype in interstitial cystitis/bladder pain syndrome.

Authors:  Michael B Fuoco; Karen Irvine-Bird; J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

7.  [The care situation of patients with interstitial cystitis in Germany: results of a survey of 270 patients].

Authors:  D Jocham; G Froehlich; F Sandig; A Ziegler
Journal:  Urologe A       Date:  2013-05       Impact factor: 0.639

8.  Symptom Duration in Patients With Urologic Chronic Pelvic Pain Syndrome is not Associated With Pain Severity, Nonurologic Syndromes and Mental Health Symptoms: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Network Study.

Authors:  Larissa V Rodríguez; Alisa J Stephens; J Quentin Clemens; Dedra Buchwald; Claire Yang; Henry H Lai; John N Krieger; Craig Newcomb; Cate S Bradley; Bruce Naliboff
Journal:  Urology       Date:  2018-11-16       Impact factor: 2.649

Review 9.  Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy.

Authors:  A S Polackwich; D A Shoskes
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-03-08       Impact factor: 5.554

Review 10.  Mechanisms of pain from urinary tract infection.

Authors:  John M Rosen; David J Klumpp
Journal:  Int J Urol       Date:  2014-04       Impact factor: 3.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.